SULT1E1 Antibody

What is SULT1E1 and why is it important in research?

SULT1E1 (Sulfotransferase family 1E member 1) is an enzyme that catalyzes the sulfate conjugation of estradiol and estrone, utilizing 3'-phospho-5'-adenylyl sulfate (PAPS) as a sulfonate donor. It is the sulfotransferase with the strongest affinity for estrogen among the known human SULT isoforms . SULT1E1 plays a crucial role in estrogen metabolism by inactivating estrogens through sulfation, potentially regulating estrogen receptor activity. This function makes it particularly relevant in hormone-dependent diseases and cancer research . Recent studies have shown significant associations between SULT1E1 expression and the progression and prognosis of various cancers, including breast cancer and lung adenocarcinoma, making it an important target for ongoing research .

What are the common applications of SULT1E1 antibodies in research?

SULT1E1 antibodies are utilized in multiple research applications, including:

• Western Blotting: For quantitative detection of SULT1E1 protein expression in tissue or cell samples

• Immunohistochemistry (IHC): For visualizing SULT1E1 expression patterns in tissue sections

• ELISA: For quantitative measurement of SULT1E1 in various sample types

• Immunofluorescence: For detecting subcellular localization of SULT1E1 in cytoplasm and nucleus

• Chromatin Immunoprecipitation (ChIP): For studying protein-DNA interactions involving SULT1E1 regulatory pathways

These applications enable researchers to investigate SULT1E1's role in normal physiology and pathological conditions, particularly in hormone-dependent diseases and cancer research.

What characteristics should researchers consider when selecting a SULT1E1 antibody?

When selecting a SULT1E1 antibody for research, consider the following key characteristics:

Additionally, researchers should review literature utilizing specific antibodies to assess performance in experiments similar to their planned application.

What are the optimal storage and handling conditions for SULT1E1 antibodies?

To maintain the integrity and effectiveness of SULT1E1 antibodies, researchers should adhere to these storage and handling guidelines:

• Store antibodies at -20°C or -80°C upon receipt, as specified by the manufacturer

• Avoid repeated freeze-thaw cycles that can degrade antibody quality and compromise experimental results

• When working with the antibody, keep it on ice or at 4°C

• Most commercial SULT1E1 antibodies are supplied in a buffer containing PBS with 0.02% sodium azide and 50% glycerol at pH 7.3 for stability

• Aliquot antibodies upon first thaw to minimize freeze-thaw cycles

• Check the expiration date and manufacturer's guidelines for specific recommendations

• For diluted working solutions, store at 4°C and use within 1-2 weeks

Proper storage and handling ensure optimal antibody performance and reproducible experimental results.

How can SULT1E1 antibodies be used to investigate genetic polymorphisms and their functional consequences?

SULT1E1 antibodies serve as valuable tools for investigating the phenotypic consequences of genetic polymorphisms in the SULT1E1 gene. Studies have identified multiple polymorphisms, including three nonsynonymous coding SNPs (cSNPs) that alter the following encoded amino acids: Asp22Tyr, Ala32Val, and Pro253His . To investigate these polymorphisms:

• Expression Analysis: Following transient expression of SULT1E1 variants in cell models (e.g., COS-1 cells), Western blotting with SULT1E1 antibodies can quantify differences in protein expression levels between wild-type and variant forms

• Functional Assessment: Changes in enzymatic activity can be correlated with immunoreactive protein levels detected by antibodies to determine if reduced activity is due to decreased protein stability or altered catalytic function

• Thermal Stability Analysis: SULT1E1 antibodies can be used to measure remaining immunoreactive protein after heat treatment at varying temperatures (28-46°C), providing insights into the structural stability of variant forms

• Population Studies: Immunohistochemical analysis with SULT1E1 antibodies in tissue samples from individuals with known genotypes can help correlate polymorphisms with tissue-specific expression patterns

For instance, research has shown that the Tyr22 and Val32 allozymes demonstrate significant decreases in both SULT1E1 activity and immunoreactive protein levels, indicating that these polymorphisms affect protein stability .

What methodological approaches are recommended for SULT1E1 detection in cancer research?

Cancer research involving SULT1E1 requires specialized methodological approaches for accurate detection and quantification. Based on recent studies, the following methodological recommendations apply:

• Multi-method Validation: Combine bioinformatics analysis with experimental validation using Western blotting, immunohistochemistry, and other techniques to confirm SULT1E1 expression patterns

• Paired Sample Analysis: Compare SULT1E1 expression in matched tumor and normal tissues from the same patient to account for individual variability

• Cellular Localization Assessment: Use immunofluorescence to detect SULT1E1 in both cytoplasmic and nuclear compartments, as subcellular localization may have functional implications

• Correlation with Clinical Parameters: Analyze SULT1E1 expression in relation to clinical staging, prognosis, and patient outcomes using proper statistical methods

• Protein Interaction Studies: Utilize co-immunoprecipitation with SULT1E1 antibodies to identify protein interaction networks, such as those constructed using the STRING database

• Functional Pathway Analysis: Combine SULT1E1 detection with analysis of downstream targets (e.g., C-myc, Cyclin D1, MMP-2, MMP-9) to elucidate functional implications

These approaches enable comprehensive characterization of SULT1E1's role in cancer development, progression, and potential therapeutic targeting.

How can researchers optimize Western blotting protocols for SULT1E1 detection?

Optimizing Western blotting for SULT1E1 detection requires careful attention to several technical parameters:

• Sample Preparation:

  • Extract total proteins using appropriate lysis buffers

  • Load 30 μg of total protein per sample for optimal detection

  • Include positive controls (tissues known to express SULT1E1, e.g., liver)

• Gel Electrophoresis:

  • Use 10-12.5% SDS-polyacrylamide gels for optimal separation

  • Include molecular weight markers to confirm the expected ~35 kDa band for SULT1E1

• Transfer and Blocking:

  • Transfer to nitrocellulose membranes for optimal antibody binding

  • Block with 5% non-fat milk or BSA to minimize background

• Antibody Selection and Dilution:

  • Use validated antibodies at manufacturer-recommended dilutions (typically 1:1000)

  • Consider polyclonal antibodies for stronger signal in tissues with low expression

• Detection System:

  • Enhanced chemiluminescence (ECL) systems provide good sensitivity for SULT1E1 detection

  • Use specialized imaging systems (e.g., AMBIS Radioanalytic Imaging System) for quantitative analysis

• Normalization:

  • Always normalize to appropriate housekeeping proteins

  • When comparing transfected cells, normalize based on transfection efficiency using co-transfected markers (e.g., β-galactosidase)

• Data Analysis:

  • Express results as percentage of wild-type SULT1E1 band intensity when comparing variants

  • Use appropriate statistical methods to analyze differences between experimental groups

These optimizations ensure reliable and reproducible detection of SULT1E1 protein across different experimental conditions.

What considerations are important when studying SULT1E1's role in oxidative stress responses?

SULT1E1 has been identified as an oxidative stress-responsive gene , making it relevant for studies exploring cellular stress responses. Key considerations include:

• Induction Analysis: Monitor changes in SULT1E1 expression using antibody-based detection methods (Western blotting, IHC) following exposure to oxidative stress agents (e.g., H₂O₂)

• Transcriptional Regulation: Investigate the involvement of transcription factors known to regulate SULT1E1 under oxidative stress conditions:

  • Use ChIP assays with antibodies against Nrf2 to detect binding to the SULT1E1 promoter region in H₂O₂-treated cells

  • Combine with EMSA to confirm specific binding interactions

• Promoter Activity Analysis: Employ reporter gene assays with cloned SULT1E1 regulatory sequences (2.5-3.0 kb) to study transcriptional activation under oxidative stress conditions

• Functional Correlation: Correlate SULT1E1 expression levels with markers of oxidative stress and cellular defense mechanisms

• Pathway Analysis: Investigate the relationship between SULT1E1 and other oxidative stress-responsive genes to determine whether they act in concert or in separate pathways

• Therapeutic Implications: Consider how modulation of SULT1E1 expression might affect cellular responses to oxidative stress and potential therapeutic applications

Understanding SULT1E1's role in oxidative stress responses may provide insights into disease mechanisms and potential therapeutic approaches.

How can researchers investigate SULT1E1's role in hormone-dependent diseases?

To investigate SULT1E1's role in hormone-dependent diseases such as breast cancer, researchers should consider these methodological approaches:

• Expression Profiling:

  • Use SULT1E1 antibodies for immunohistochemistry and Western blotting to compare expression levels in normal versus diseased tissues

  • Correlate expression with disease stage, progression, and patient outcomes

• Functional Studies:

  • Employ gain-of-function and loss-of-function approaches:

    • Overexpress SULT1E1 to assess effects on cell proliferation, apoptosis, and cell cycle progression

    • Use siRNA or CRISPR-Cas9 to knockdown/knockout SULT1E1 and observe phenotypic consequences

• Pathway Analysis:

  • Investigate SULT1E1's interaction with key signaling pathways:

    • PPARγ activation has been shown to be required for SULT1E1-mediated downregulation of C-myc, Cyclin D1, MMP-2, and MMP-9

    • Assess effects on estrogen receptor activity and downstream targets

• In Vivo Models:

  • Use SULT1E1 antibodies to validate expression changes in animal models of hormone-dependent diseases

  • Correlate SULT1E1 expression with tumor growth, metastasis, and response to therapy

• Clinical Correlation:

  • Analyze SULT1E1 expression in patient samples in relation to:

    • Response to hormone therapy

    • Disease recurrence and survival outcomes

    • Correlation with established prognostic markers

Research has shown that SULT1E1 can inhibit breast cancer cell growth by inducing apoptosis and arresting cell cycle progression, and can suppress tumor cell migration and invasion . These findings highlight SULT1E1's potential as both a biomarker and therapeutic target in hormone-dependent diseases.

What are common challenges in SULT1E1 antibody-based experiments and how can they be addressed?

Researchers may encounter several challenges when using SULT1E1 antibodies. Here are common issues and mitigation strategies:

Additionally, when working with tissues known to have variable SULT1E1 expression (e.g., intestine or liver samples) , researchers should consider pooling samples or increasing replicate numbers to account for individual variation.

How can researchers validate the specificity of their SULT1E1 antibody?

Validating antibody specificity is crucial for reliable SULT1E1 research. Implement these validation approaches:

• Positive and Negative Controls:

  • Use tissues or cell lines with known SULT1E1 expression as positive controls

  • Include tissues or cells that do not express SULT1E1 as negative controls

  • Consider using SULT1E1 knockout models or CRISPR-edited cell lines as definitive negative controls

• Peptide Competition Assays:

  • Pre-incubate the antibody with excess purified SULT1E1 protein or immunizing peptide

  • A specific antibody will show significantly reduced or eliminated signal

• Multiple Antibody Validation:

  • Compare results using different antibodies targeting distinct epitopes of SULT1E1

  • Concordant results increase confidence in specificity

• RNA-Protein Correlation:

  • Correlate protein detection by the antibody with mRNA expression data

  • Similar patterns suggest specific target recognition

• Molecular Weight Verification:

  • Confirm that detected bands match the expected molecular weight of SULT1E1 (~35 kDa)

  • Be aware of potential post-translational modifications that may alter apparent molecular weight

• Recombinant Protein Standards:

  • Include purified recombinant SULT1E1 protein as a standard

  • Compare migration pattern and immunoreactivity

These validation steps ensure that experimental findings reflect genuine SULT1E1 biology rather than antibody artifacts.

How can SULT1E1 antibodies be used to investigate its role as a biomarker in cancer?

Recent studies suggest SULT1E1 may serve as a biomarker in various cancers, including lung adenocarcinoma and breast cancer . Researchers can leverage SULT1E1 antibodies to explore this potential through:

• Tissue Microarray Analysis:

  • Use immunohistochemical staining with SULT1E1 antibodies on tissue microarrays containing samples from multiple patients

  • Correlate expression levels with clinical outcomes, disease stage, and other prognostic indicators

• Multiplexed Biomarker Panels:

  • Combine SULT1E1 detection with other established or candidate biomarkers

  • Develop integrated scoring systems for improved diagnostic or prognostic value

• Liquid Biopsy Applications:

  • Investigate whether SULT1E1 can be detected in circulating tumor cells or exosomes

  • Develop sensitive immunoassays for detection in blood or other biological fluids

• Therapeutic Response Prediction:

  • Analyze whether SULT1E1 expression patterns correlate with response to specific therapies

  • Study pre- and post-treatment samples to assess changes in expression

• Subtype Classification:

  • Determine if SULT1E1 expression helps distinguish between cancer subtypes

  • Integrate with molecular classification systems for improved precision

For example, significant reductions in SULT1E1 expression have been observed in lung adenocarcinoma tissues and cell lines, suggesting its potential as a biomarker for this cancer type . Additionally, SULT1E1 expression has been associated with breast cancer prognosis, though with somewhat contradictory findings across studies .

What approaches are recommended for studying SULT1E1's interaction with other molecular pathways?

To elucidate SULT1E1's interactions with other molecular pathways, researchers should employ these sophisticated approaches:

• Protein-Protein Interaction Studies:

  • Use co-immunoprecipitation with SULT1E1 antibodies followed by mass spectrometry to identify interaction partners

  • Construct protein interaction networks using databases like STRING to predict functional relationships

  • Validate key interactions using techniques like proximity ligation assay or FRET

• Pathway Cross-talk Analysis:

  • Investigate SULT1E1's relationship with key signaling pathways:

    • PPARγ pathway (SULT1E1 has been shown to activate PPARγ)

    • Estrogen receptor signaling pathway

    • Protein serine/threonine kinase activity pathways

    • Drug metabolism pathways

• Functional Genomics:

  • Combine SULT1E1 modulation (overexpression or knockdown) with transcriptomic or proteomic analysis

  • Perform Gene Ontology (GO) and pathway enrichment analyses to identify affected biological processes

  • Use GSEA (Gene Set Enrichment Analysis) to identify pathway signatures associated with SULT1E1 expression

• In Silico Modeling:

  • Develop computational models of SULT1E1's role in metabolic and signaling networks

  • Predict functional consequences of genetic polymorphisms or expression changes

• Multi-omics Integration:

  • Correlate SULT1E1 expression with genomic, transcriptomic, proteomic, and metabolomic data

  • Identify potential causal relationships between SULT1E1 and downstream effects

For example, research has revealed that SULT1E1 influences drug metabolism, choline metabolism in cancer, and hormone synthesis pathways , and activates PPARγ to downregulate C-myc, Cyclin D1, MMP-2, and MMP-9, affecting cell proliferation and invasion .